163 related articles for article (PubMed ID: 26694163)
21. MicroRNA-101 is a potential prognostic indicator of laryngeal squamous cell carcinoma and modulates CDK8.
Li M; Tian L; Ren H; Chen X; Wang Y; Ge J; Wu S; Sun Y; Liu M; Xiao H
J Transl Med; 2015 Aug; 13():271. PubMed ID: 26286725
[TBL] [Abstract][Full Text] [Related]
22. miR-140-5p targeted FGF9 and inhibited the cell growth of laryngeal squamous cell carcinoma.
Wang Y; Huang Q; Li F
Biochem Cell Biol; 2020 Apr; 98(2):83-89. PubMed ID: 31867983
[TBL] [Abstract][Full Text] [Related]
23. miR-205 promotes proliferation and invasion of laryngeal squamous cell carcinoma by suppressing CDK2AP1 expression.
Zhong G; Xiong X
Biol Res; 2015 Oct; 48():60. PubMed ID: 26515287
[TBL] [Abstract][Full Text] [Related]
24. MiRNA-mRNA crosstalk in laryngeal squamous cell carcinoma based on the TCGA database.
Huang GJ; Luo MS; Chen GP; Fu MY
Eur Arch Otorhinolaryngol; 2018 Mar; 275(3):751-759. PubMed ID: 29332170
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA‑34a/c function as tumor suppressors in Hep‑2 laryngeal carcinoma cells and may reduce GALNT7 expression.
Li W; Ma H; Sun J
Mol Med Rep; 2014 Apr; 9(4):1293-8. PubMed ID: 24482044
[TBL] [Abstract][Full Text] [Related]
26. [Global gene expression profiling of laryngeal squamous cell carcinoma by laser capture microdissection and complementary DNA microarrays].
Ma LJ; Tian YQ; Xiao JY; Li W; Zhang H; Zhang X; Huang DH
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2008 Sep; 43(9):696-700. PubMed ID: 19035265
[TBL] [Abstract][Full Text] [Related]
27. Establishment and characterization of a novel HPV-negative laryngeal squamous cell carcinoma cell line, FD-LSC-1, with missense and nonsense mutations of TP53 in the DNA-binding domain.
Wu CP; Zhou L; Gong HL; Du HD; Tian J; Sun S; Li JY
Cancer Lett; 2014 Jan; 342(1):92-103. PubMed ID: 24001612
[TBL] [Abstract][Full Text] [Related]
28. Promoter hypermethylation of miR-34a contributes to the risk, progression, metastasis and poor survival of laryngeal squamous cell carcinoma.
Shen Z; Zhou C; Li J; Ye D; Li Q; Wang J; Cui X; Chen X; Bao T; Duan S
Gene; 2016 Nov; 593(2):272-6. PubMed ID: 27450916
[TBL] [Abstract][Full Text] [Related]
29. New miRNA expression abnormalities in laryngeal squamous cell carcinoma.
Cybula M; Wieteska Ƚ; Józefowicz-Korczyńska M; Karbownik MS; Grzelczyk WL; Szemraj J
Cancer Biomark; 2016; 16(4):559-68. PubMed ID: 27002759
[TBL] [Abstract][Full Text] [Related]
30. miR-1297 mediates PTEN expression and contributes to cell progression in LSCC.
Li X; Wang HL; Peng X; Zhou HF; Wang X
Biochem Biophys Res Commun; 2012 Oct; 427(2):254-60. PubMed ID: 22995297
[TBL] [Abstract][Full Text] [Related]
31. MiR-613 suppressed the laryngeal squamous cell carcinoma progression through regulating PDK1.
Wang J; Yang S; Ge W; Wang Y; Han C; Li M
J Cell Biochem; 2018 Jul; 119(7):5118-5125. PubMed ID: 29091303
[TBL] [Abstract][Full Text] [Related]
32. A Comprehensive Evaluation of miR-144-3p Expression and Its Targets in Laryngeal Squamous Cell Carcinoma.
Mo BY; Pang JS; Dai WB; Su YS; Jiang W; Huang SN
Comput Math Methods Med; 2021; 2021():6684186. PubMed ID: 34326893
[TBL] [Abstract][Full Text] [Related]
33. Single nucleotide polymorphism rs11614913 associated with CC genotype in miR-196a2 is overrepresented in laryngeal squamous cell carcinoma, but not salivary gland tumors in Polish population.
Skalski M; Ustaszewski A; Jaskiewicz K; Kiwerska K; Wierzbicka M; Klimza H; Grenman R; Giefing M
J Appl Genet; 2018 Aug; 59(3):301-304. PubMed ID: 29705927
[TBL] [Abstract][Full Text] [Related]
34. Identification of miRNA-mRNA crosstalk in laryngeal squamous cell carcinoma.
Fei Y; Guo P; Wang F; Li H; Lei Y; Li W; Xun X; Lu F
Mol Med Rep; 2017 Oct; 16(4):4179-4186. PubMed ID: 28765949
[TBL] [Abstract][Full Text] [Related]
35. CDR1as is overexpressed in laryngeal squamous cell carcinoma to promote the tumour's progression via miR-7 signals.
Zhang J; Hu H; Zhao Y; Zhao Y
Cell Prolif; 2018 Dec; 51(6):e12521. PubMed ID: 30182381
[TBL] [Abstract][Full Text] [Related]
36. Long noncoding RNA NEAT1 promotes laryngeal squamous cell cancer through regulating miR-107/CDK6 pathway.
Wang P; Wu T; Zhou H; Jin Q; He G; Yu H; Xuan L; Wang X; Tian L; Sun Y; Liu M; Qu L
J Exp Clin Cancer Res; 2016 Jan; 35():22. PubMed ID: 26822763
[TBL] [Abstract][Full Text] [Related]
37. Downregulated Chibby in laryngeal squamous cell carcinoma with increased expression in laryngeal carcinoma Hep-2 cells.
Xu J; Ren G; Zhao DA; Li BA; Cai CF; Zhou Y; Luo XY
Oncol Rep; 2014 Nov; 32(5):1947-56. PubMed ID: 25175341
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA expression profiles in supraglottic carcinoma.
Zhang T; Han G; Wang Y; Chen K; Sun Y
Oncol Rep; 2014 May; 31(5):2029-34. PubMed ID: 24676647
[TBL] [Abstract][Full Text] [Related]
39. Dysregulated microRNAs in laryngeal cancer: a comprehensive meta-analysis using a robust rank aggregation approach.
Cao Z; Guo Y; Ao Y; Zhou S
Future Oncol; 2020 Nov; 16(33):2723-2734. PubMed ID: 32812475
[TBL] [Abstract][Full Text] [Related]
40. Integrated transcriptome analysis reveals miRNA-mRNA crosstalk in laryngeal squamous cell carcinoma.
Zhang Y; Chen Y; Yu J; Liu G; Huang Z
Genomics; 2014 Oct; 104(4):249-56. PubMed ID: 24979738
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
